Shanghai Shyndec Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2024: USD 1.12

Shanghai Shyndec Pharmaceutical Co., Ltd. Revenue Per Share is USD 1.12 for the year ending December 31, 2024, a -15.36% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2023 was USD 1.32, a -27.83% change year over year.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 1.83, a -14.43% change year over year.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 2.14, a 14.09% change year over year.
  • Shanghai Shyndec Pharmaceutical Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 1.87, a 9.81% change year over year.
Key Data
Date Revenue Per Share Free Cash Flow Per Share Dividend Per Share Debt to Equity Ratio